This consensus document provides guidance on pharmacologic pre-treatment for myocardial revascularization, emphasizing early coronary angiography for high-risk patients.
Informs pre-treatment decisions before revascularization in high-risk patients; extends prior revascularization guidelines with risk-stratified recommendations.
No abstract was published with this document — society guidelines, consensus pathways, and scientific statements are typically released without one. See the Key Points and the linked PDF for the full content.
No takes yet. Share an insight, caveat, or question.
Caporale et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: